Summary:
The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW) at the University of Copenhagen is excited to announce a PhD position in ATMP (Advanced Therapy Medicinal Product) Development, focusing on the development of a cutting-edge stem cell therapy for the treatment of patients with ulcerative colitis. The position provides an exceptional opportunity to be part of an interdisciplinary team at a leading research institution.
PhD Position in ATMP Development at reNEW – University of Copenhagen
Designation:
PhD Candidate
Research Area:
Stem cell therapy for the treatment of patients with ulcerative colitis
Location:
University of Copenhagen, Faculty of Health and Medical Sciences, Denmark
Eligibility/Qualification:
- Master’s degree in Life Sciences
- Strong background in cellular and molecular biology
- FELASA EU function ABD license (preferred)
- Previous experience with culturing human intestinal organoids (preferred)
- Fluency in English (essential), fluency in Danish (advantageous)
Job Description:
The selected candidate will play a pivotal role in the development of methods and procedures for a clinical trial of a stem cell therapy for the treatment of patients with ulcerative colitis. Key activities include:
- Adapting current cell culture conditions to be GMP compatible
- Developing standard operating procedures for culturing intestinal epithelial organoids
- Supporting the transition to a GMP facility
- Establishing transplantation methods suitable for patients
- Evaluating safety and efficacy of the cellular products
- Establishing quality control and release criteria measurement of the cellular product
How to Apply:
Interested candidates can submit their online applications in English via the university’s website before the deadline. The application must include a motivated letter of application, curriculum vitae, reference letters, list of publications, and copies of diplomas/degree certificates in PDF format.
Last Date for Apply:
18 September 2024, 23:59 CET
